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a  b  s  t  r  a  c  t
ATP-binding  cassette  transporter  A1  mediates  the export  of  excess  cholesterol  from  macrophages,  con-
tributing  to the  prevention  of  atherosclerosis.  Advanced  glycated  albumin  (AGE-alb)  is prevalent  in
diabetes  mellitus  and  is  associated  with  the development  of  atherosclerosis.  Independently  of  changes  in
ABCA-1  mRNA  levels,  AGE-alb  induces  oxidative  stress  and  reduces  ABCA-1  protein  levels,  which  leads  to
macrophage  lipid  accumulation.  These  metabolic  conditions  are  known  to  elicit  endoplasmic  reticulum
(ER)  stress.  We  sought  to  determine  if AGE-alb  induces  ER  stress  and  unfolded  protein  response  (UPR)
in  macrophages  and  how  disturbances  to  the  ER  could  affect  ABCA-1  content  and  cholesterol  efﬂux  in
macrophages.  AGE-alb  induced  a  time-dependent  increase  in  ER  stress  and UPR markers.  ABCA-1  content
and cellular  cholesterol  efﬂux  were  reduced  by  33%  and  47%,  respectively,  in  macrophages  treated  with
AGE-alb,  and  both  were  restored  by  treatment  with  4-phenyl  butyric  acid  (a chemical  chaperone  that  alle-
viates  ER  stress),  but not  MG132  (a proteasome  inhibitor).  Tunicamycin,  a classical  ER  stress  inductor,  alsoeverse cholesterol transport impaired ABCA-1  expression  and  cholesterol  efﬂux  (showing  a  decrease  of 61%  and  82%, respectively),
conﬁrming  the  deleterious  effect  of ER  stress  in macrophage  cholesterol  accumulation.  Glycoxidation
induces  macrophage  ER  stress,  which  relates  to the  reduction  in  ABCA-1  and  in reverse  cholesterol  trans-
port, endorsing  the adverse  effect  of  macrophage  ER  stress  in  atherosclerosis.  Thus,  chemical  chaperones
that  alleviate  ER  stress  may  represent  a  useful  tool  for  the  prevention  and  treatment  of  atherosclerosis
in  diabetes.. Introduction
In diabetes mellitus (DM), cardiovascular disease is the major
ause of morbidity and mortality (Earl, 2011). In particular, alter-
tions along the reverse cholesterol transport (RCT) system that
re associated with the development of atherosclerosis have been
escribed in DM (Tan, 2009). The RCT system allows excess
Abbreviations: ABCA-1, ATP binding cassette transporter class A type I; ABCG-
, ATPbinding cassette transporter class G type I; AGE, advanced glycation end
roducts; AGE-alb, advanced glycated albumin; Apo A-I, apolipoprotein A-I; ATF6,
ctivating transcription factor 6; CML, carboxymethyllysine; DM, diabetes melli-
us; eIf2˛, eukaryotic translation initiation factor2 subunit 1alpha; ER,  endoplasmic
eticulum; FAFA, fatty acid-free albumin; FCS, fetal calf serum; GAD, glycolaldehyde;
rp78,  glucose-regulated protein 78 kDa; Grp94,  glucose-regulated protein 94 kDa;
DL, high density lipoprotein; LDL, low density lipoprotein; 4-PBA, 4-phenyl butyric
cid; RAGE, receptor for advanced glycation end-products; ROS, reactive oxygen
pecies; Tun, tunicamycin; UPR, unfolded protein response.
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of cholesterol to be removed from arterial macrophages by lipid-
free Apo A-I and HDL and then transported to the liver for bile
excretion. The removal of cellular cholesterol is mainly driven
by the ATP cassette transporter type 1 (ABCA-1) which mediates
cholesterol export to plasma Apo A-I by utilizing free energy from
ATP hydrolysis (Tang and Oram, 2009). ABCA-1 is a short-lived,
220 kDa plasma membrane protein. Its expression and activity are
primarily regulated by the oxysterols-activated liver X receptor
(LXR), although posttranslational modiﬁcations also inﬂuence its
ﬁnal protein content (Tall et al., 2002; Wellington et al., 2002).
In DM,  cellular stressors, including reactive oxygen species
(ROS), inﬂammatory cytokines, hexosamine pathway derivatives
and lipid accumulation, lead to endoplasmic reticulum (ER) stress.
ER stress is known to activate the unfolded protein response (UPR)
as an adaptive response to the accumulation of misfolded pro-
teins in the lumen of the organelle (Ron and Walter, 2007). During
the UPR, sequential activation of ER-resident proteins mediates a
Open access under the Elsevier OA license.cascade of events that promote cell adaptation and survival. As a
short-term response, cell translational machinery is shut off via
PERK-mediated phosphorylation of eIF2, which helps to prevent
the entrance of additional misfolded proteins into the ER. Next,
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RE1 and ATF6 activation lead to an increase in the expression
f Grp78 and Grp94 chaperones, and subsequently triggers an
ntioxidant defense that aids in the proper folding of proteins. In
ddition, unfolded proteins are continuously cleared by ubiquitina-
ion and proteasomal cleavage in a process known as endoplasmic
eticulum-associated degradation (ERAD). Finally, if translational
omeostasis is not satisfactorily achieved, the pro-apoptotic ATF-
/CHOP-mediated pathway can be elicited, resulting in cell death
Zhang and Kaufman, 2008). In both humans and animal models,
PR markers are enhanced in atherosclerotic lesions and have also
een associated with plaque instability and rupture in atheroscle-
osis (Myoishi et al., 2007; Zhou et al., 2005; Tsukano et al., 2010).
Advanced glycation end products (AGE) are prevalent in DM
nd mainly associate with serum albumin (AGE-alb), which corre-
ponds to 80% of the total glycated proteins in circulation (Cohen,
003). AGE-alb enhances ROS generation and induces intracellu-
ar lipid accumulation by impairing the expression of ABCA-1 (de
ouza Pinto et al., 2012). However, this effect is not related to
lterations in ABCA-1 gene transcription or mRNA levels (Passarelli
t al., 2005; Isoda et al., 2007). Considering that the activation of
R stress following AGE-alb treatment has not been reported in
acrophages, the aim of this study was to evaluate whether ER
tress mediates the reduction in ABCA-1 protein expression and in
holesterol efﬂux induced by AGE-alb. In addition, we  sought to
ssess the effect of a chemical chaperone that alleviates ER stress
4-phenyl butyric acid; 4-PBA) on ABCA-1 cell content and choles-
erol efﬂux. Understanding how ER stress modulates ABCA-1 levels
n cells under glycoxidative stress will help to elucidate the role of
yperglycemia in foam cell formation in DM.
. Material and methods
.1. Preparation of AGE-albumin
AGE-alb was prepared by incubating fatty acid free albumin
FAFA, 40 mg/mL) with 10 mM glycolaldehyde (GAD; Sigma Chem.
om. St. Louis, MO)  for 4 days, at 37 ◦C under sterile conditions and
 nitrogen atmosphere in a water bath shaker in the dark. Control
lbumin (C-alb) was prepared under the same conditions, how-
ver incubated with PBS only. After extensive dialysis, the samples
ere sterilized in a 0.22 m ﬁlter. All albumin samples contained
50 pg endotoxin/mL as determined using the chromogenic Limu-
us amebocyte assay (Cape Cod, Falmouth, MA).
.2. AGE determination in albumin samples
The determination of AGE in albumin samples was  performed
ccording to Pageon et al. (2007).  Brielﬂy, AGE and C-alb samples
ere diluted to 1 mg/mL  and ﬂuorescence intensity was  measured
t 440 nm ( emission) and 370 nm ( excitation).
.3. Cell culture
Mouse peritoneal macrophages were harvested after the injec-
ion of 6 mL  of PBS into the peritoneal cavity. After a soft abdominal
assage, cells were collected into sterile tubes, centrifuged and
esuspended in RPMI 1640 containing 10% fetal calf serum (FCS),
% penicillin–streptomycin and 4 mM l-glutamine. The cells were
hen plated in Petri dishes or 48 well-plates. J774 cells (a tumoral
urine macrophage cell line) were cultured in RPMI 1640 con-
aining 10% FCS, 1% penicillin–streptomycin and 4 mM l-glutamine
nd maintained in a 5% CO2 incubator at 37 ◦C. During the different
xperimental treatments described below, cells were maintained
n DMEM, and cell viability was assured by exclusion of trypan blue
higher than 99%) and lactate dehydrogenase release to cell culture
edium (In vitro toxicology assay kit, Sigma Aldrich, St Louis, MO,emistry & Cell Biology 44 (2012) 1078– 1086 1079
USA) in all experimental conditions. No change in apoptosis was
observed after exposure to AGE-alb, as assessed by the number of
Annexin V-FITC positive cells (data not shown).
2.4. Assessment of carbonyl content in macrophages
To determine the carbonyl content in macrophages, lysates
from C or AGE-alb-treated cells were incubated with 10 mM of
dinitrophenilhydrazine in 2.5 M HCl for 1 hour at room tem-
perature. The reaction was blocked by the addition of 20%
trichloroacetic acid (TCA). The pellets were washed twice with
absolute ethanol/ethylacetate (1:1) and once with 10% TCA. The
protein pellets were dissolved in 6 M guanidine hydrochloride and
the absorption at 370 nm was  determined. Carbonyl content was
calculated using the molar absorption coefﬁcient of aliphatic hydra-
zones of 22,000 M−1 cm−1 and expressed as nanomoles carbonyl
per milligram of protein.
2.5. Immunoblotting
Mouse peritoneal macrophages were treated with C- or AGE-alb
for different intervals and were also treated with C- or AGE-alb in
the absence or presence of 2.5 or 5.0 mM 4-PBA (Alpha Aeser, Ward
Hill, MA). Following treatment, cells were scraped into Tris buffered
saline containing protease inhibitors, and equal amounts of cel-
lular protein were applied to a polyacrylamide gel (SDS-PAGE).
The expressions of Grp78, Grp94, eIF2-P, ATF-6, ubiquitin, PDI,
CHOP and -actin were determined using the following antibodies,
respectively: anti-KDEL (Stressgen, Ann Arbor, MI, EUA), anti-
eIf2-P (Upstate Biotechnology), anti-ATF6 (Abcam, Cambridge,
MA,  EUA), anti-ubiquitin (ZYMED® Laboratories Carlsbad, CA, EUA),
anti-PDI (Stressgen), anti-CHOP (ABR-Afﬁnity Bioreagents, Fisher
Scientiﬁc, USA) and anti--actin (Fitzgerald Industries Interna-
tional Inc., Concord, MA). Tunicamycin (2 g/mL) was used as
a positive control for the induction of ER stress. Proteins were
detected with horseradish peroxidase-conjugated antibodies and
an enhanced chemiluminescence reagent (Pierce, Rockford, IL).
Immunoblot band density was  quantiﬁed using an ImageQuant
300 Imager (GE Healthcare), and differences between the bands
were analyzed in pixels, using the ImageQuant TL software (GE
Healthcare). The results were expressed as arbitrary units, analyzing
AGE-alb versus C-alb normalized to -actin expression.
2.6. ABCA-1 protein content
Due to the need for a higher number of cells, J774 macrophages
were used in ﬂow cytometry assays instead of mouse peritoneal
macrophages. J774 macrophages were pre-incubated with 0.5 mM
8-bromoadenosine-3′, 5′-cyclic monophosphate (cAMP) (Sigma
Aldrich) and were treated for 8 h with C- or AGE-alb in the pres-
ence or absence of the ER stress inhibitor 4-PBA (2.5 or 5.0 mM)
or the proteasome inhibitor MG132 (1 M).  MG132 was  added
to the culture in the last 2 h of incubation with albumins, while
4-PBA was  added simultaneously with the albumins In some incu-
bations, cells were treated with tunicamycin (2 g/mL for 18 h).
To assess the ABCA-1 content on the macrophage surface, a total
of 1 × 106 cells were trypsinized, washed extensively with PBS
and ﬁxed in 4% paraformaldehyde. After ﬁxation, cells were incu-
bated with anti-ABCA-1 antibody (Novus Biologicals, Inc., Littleton,
CO – 1:250 dilution) for 1 h at room temperature, rinsed in PBS
and incubated with 4 g/mL Alexa Fluor 488 antibody (Invitro-
gen, USA). Cellular ﬂuorescence intensity was  evaluated by ﬂow
cytometry using a FACS Calibur and Cellquest Software (B.D., San
Jose, CA). All of the conditions were corrected to basal cellular
ﬂuorescence (cells without antibody labeling). The total cellular
ABCA-1 content was determined by immunocytochemistry. Brieﬂy,
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Fig. 1. Increased expression of ER stress and UPR markers in macrophages treated with AGE-alb. Mouse peritoneal macrophages were treated for different periods of time
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ere  performed to measure the expression of (A) Grp78 (8 h treatment); (B) Grp78 (2
s  arbitrary units corrected to -actin levels (representative ﬁgure from two  indepe
ouse peritoneal macrophages were seeded on coated cover slips
nd allowed to adhere for 2 days. After pre-treatment with 0.5 mM
AMP macrophages were incubated with C- or AGE-alb for 8 h in the
resence or absence of 4-PBA and MG132. Cells were then washed
ith PBS and ﬁxed with ice-cold 70% ethanol for 10 min  and rehy-
rated with PBS. Cells were then permeabilized with 0.05% Tween
0 and incubated in a blocking solution containing 1% FAFA for
0 min  at 37 ◦C. After blocking, cells were incubated for 2 h at 37 ◦C
ith the anti-ABCA-1 antibody (Novus Biologicals 1:250), washed
nd labeled with horseradish peroxidase conjugated-secondary
ntibody (Novus Biological 1:800) for 90 min  at 4 ◦C. Finally, cells
ere stained with 3,3′-diaminobenzidine (DAB) for 3 min  and after
hromogen development, the slides were washed in distilled water
nd counterstained with hematoxylin (30 s). The samples were
lindly analyzed, and brownish yellow granular deposits were con-
idered positive areas. QWin V3 Standard was used to perform
emiquantitative evaluation under a light microscope, and the inte-
rated optical density of the positively stained area was  measured
t a magniﬁcation of 400×. Measurements were taken from 4
andom ﬁelds in each slide, and 4 slides were assessed for each
ondition. Data were expressed as integrated optical density per
roup.
.7. ABCA-1 mRNA by real time RT-PCR
Total RNA from macrophages treated with C- or AGE-alb was
solated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). RNA
uality was assessed using a Bioanalyzer 2100 (Agilent Technolo-
ies, Palo Alto, CA). Real-time RT-PCR was conducted using TaqMan
wo step RT-PCR (Applied Biosystems, Foster City, CA, USA). Thein were loaded onto polyacrylamide gels, and electrophoresis and immunoblotting
); (C) Grp94 (2–18 h); (D) ATF6 (2–18 h) and (E) eIF2-P (2–18 h). Data are expressed
t experiments).
following TaqMan Gene Expression Assay was  used: Mouse ABCA-
1 (Mm00442663 m1)  in the Step One Plus Real Time PCR System
(Applied Biosystems, Foster City, CA, USA). The results were cor-
rected to the internal -actin gene (Mm00607939 s1), and relative
quantiﬁcation analysis was performed with StepOne Software 2.0
(Applied Biosystems, Foster City, CA, USA) using the comparative
cycle threshold (Ct) (2−Ct) method.
2.8. LDL isolation and acetylation
Low-density lipoprotein (LDL, d = 1.019–1.063 g/mL) was iso-
lated after sequential preparative ultracentrifugation of fresh
plasma drawn from healthy donors and puriﬁed by discontinuous
gradient ultracentrifugation. After dialysis, the protein concentra-
tion was  measured by the Lowry protocol (Lowry et al., 1951) and
acetylation performed according to Basu et al. (1976),  followed by
extensive dialysis and sterilization in a 0.22 m ﬁlter.
2.9. Cholesterol efﬂux assay
Mouse peritoneal macrophages were cultured in RPMI 1640
containing 10%, penicillin and streptomycin and were maintained
in a 5% CO2 incubator at 37 ◦C. Cells were enriched with acety-
lated LDL (50 g/mL) and 0.3 Ci/mL of 14C-cholesterol (Perkin
Elmer, Boston, MA,  USA) for 48 h. After two  washes with PBS
containing FAFA, cells were maintained for 24 h in DMEM con-
taining FAFA and cAMP, followed by 8 hours of incubation with
2 mg/mL  C- or AGE-alb both in the absence or presence of 5 mM
4-PBA. In some experiments, macrophages were treated with tuni-
camycin (2 g/mL) for 18 h. Macrophages were then incubated with
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0 g/mL Apo A-I (Sigma Aldrich) for 8 h to determine the 14C-
holesterol efﬂux, as previously described (Machado et al., 2006).
.10. Statistical analysis
Statistical analyses were performed using GraphPad Prism 4.0
oftware (GraphPad Prism, Inc., San Diego, CA), and the Student’s t
est was used to evaluate each group. Summary data are reported
s the mean values ± standard deviation. A p-value <0.05 was  con-
idered statistically signiﬁcant.
. ResultsGlycolaldehyde-modiﬁed albumin presented an increased ﬂu-
rescence proﬁle regarding total AGE when compared to C-alb
amples (53,330 ± 15,824 vs. 1388 ± 368; p = 0.0047). In addi-
ion, previous studies from our group showed derivatization by-alb. Macrophages were treated for 8 h with C- or AGE-alb (2 mg/mL). (A) ABCA-1
unocytochemistry in mouse peritoneal macrophages (representative images are
carboxymethyllysine following albumin treatment in the same
conditions as the present investigation (de Souza Pinto et al., 2012).
The carbonyl content was  higher in macrophages incubated with
AGE-alb in comparison to cells treated with C-alb (respectively,
24.11 ± 2.01 and 17.10 ± 1.07 nanomoles of carbonyls per mil-
ligram of protein, n = 4; p = 0.0209).
Mouse peritoneal macrophages treated for 8 h with AGE-alb
displayed increased expression of Grp78, which is considered
a hallmark of ER stress activation (Fig. 1A). A time-dependent
increase in the expression of Grp78 and Grp94 (Fig. 1B and C)
was  observed, with the most substantial increase at 8 hour after
treatment, followed by a slight decrease overtime. At 18 h, AGE-
alb-induced chaperone expression was still much higher compared
to C-alb-treated macrophages. As expected, tunicamycin induced
a 15% and 25% increase in Grp78 and Grp94, respectively. Sim-
ilarly, the expression of ATF6 and eIF2-P was also induced in
a time-dependent manner in macrophages treated with AGE-alb
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Fig. 3. 4-PBA alleviates ER stress and restores ABCA-1 content and Apo A-I-mediated 14C-cholesterol efﬂux. Mouse peritoneal macrophages were treated for 8 hours with
C-  or AGE-alb (2 mg/mL) in the absence or presence of 2.5 or 5.0 mM 4-PBA. Equal amounts of cellular protein were loaded onto a polyacrylamide gel, and electrophoresis
and  immunoblotting were performed to measure the expression of A) Grp78 (n = 3), B) ATF6 (n = 3) and C) eIF2-P (n = 3). Data are expressed as arbitrary units corrected
t  J774 m
( terol 
( 8 h).
(
i
m
wo  -actin levels. (D) ABCA-1 content was determined by ﬂow cytometry (n = 6) in
representative images are shown below; n = 4). (F) Acetylated-LDL and 14C-choles
2  mg/mL), and cholesterol efﬂux to Apo A-I was assessed (30 g/mL of Apo A-I for Fig. 1D and E). In agreement to our previous results, follow-
ng an 18 hour-treatment, expression of these UPR markers was
uch higher compared to cells exposed to C-alb. No changes
ere observed in protein desulﬁde isomerase (PDI) or CHOPacrophages and by (E) immunocytochemistry in mouse peritoneal macrophages
enriched-mouse peritoneal macrophages were treated for 8 h with C- or AGE-albexpression when macrophages were exposed to AGE-alb (data not
shown).
Macrophages treated with AGE-alb did not alter the ABCA-
1 mRNA levels when compared with C-alb-treated cells (Fig. 2
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Fig. 4. ER stress elicited by tunicamycin reduces ABCA-1 protein levels and Apo A-
I-mediated cholesterol efﬂux. Mouse peritoneal macrophages were treated for 18 h
with tunicamycin (Tun-2 g/mL), and control incubations were preformed in the
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2010; Hetz et al., 2006). Unpublished data from our group indi-rol  incubations were preformed in the presence of DMEM alone. Cholesterol efﬂux
as  determined after macrophage incubation with Apo A-I (30 g/mL) for 8 h.
nner panel). However, the ABCA-1 protein level, assessed by ﬂow
ytometry and immunocytochemistry, was reduced by 33% and
5%, respectively, in AGE-alb-treated macrophages compared with
ells treated with C-alb (Fig. 2A and B). Thus, both surface ABCA-
, as determined by ﬂow cytometry, and total ABCA-1 content, as
ssessed by immunocytochemistry, were reduced in macrophages
reated with AGE-alb.
AGE-alb-induced ER stress was alleviated by incubation with
-PBA, as was demonstrated by the reduction in Grp78 expres-
ion (Fig. 3A). In agreement with this result, the expression of UPR
arkers (ATF6 and eIF2-P) was also reduced when macrophages
ere incubated with 4-PBA (Fig. 3B and C). Furthermore, 4-PBA
2.5 mM)  prevented the reduction of ABCA-1 protein levels induced
y AGE-alb (Fig. 3D). These results were conﬁrmed using immuno-
ytochemistry, utilizing 4-PBA at a 5 mM concentration (Fig. 3E).
A 47% reduction in Apo A-I-mediated cholesterol efﬂux was
bserved in cells treated with AGE-alb compared to C-alb; how-
ver, in the presence of 5 mM 4-PBA this difference was  no longer
bserved between cells treated with AGE-alb and C-alb (Fig. 3F).
hese data agree with the recovery of the ABCA-1 protein level
fter inhibition of ER stress with 4-PBA. The association between ERemistry & Cell Biology 44 (2012) 1078– 1086 1083
stress and the impairment of cholesterol efﬂux was also conﬁrmed
by incubation with tunicamycin, which reduced ABCA-1 protein
content in 61% (Fig. 4A) and reduced Apo A-I mediated cholesterol
efﬂux by 82% (Fig. 4B).
An exponential increase was observed in the total ubiquitin
content of macrophages treated with AGE-alb over time (Fig. 5A).
Incubation of macrophages with the proteasomal inhibitor, MG132,
was  unable to restore the diminished expression of ABCA-1
(Fig. 5B). Similar results were observed by immunocytochemistry
(Fig. 5C). Therefore, the possibility of a proteasomal-mediated
pathway targeting ABCA-1 degradation in macrophages treated
with AGE-alb was excluded.
4. Discussion
In the setting of hyperglycemia, intracellular cholesterol accu-
mulation, oxidative stress, inﬂammation and the accumulation of
several different metabolites predict the ER stress response, which
has been described as an important contributor to DM complica-
tions (Sage et al., 2010; Alhusaini et al., 2010).
In the present study, we  demonstrated that in macrophages,
AGE-alb induces ER stress, which is related to the impairment
in macrophage RCT. The expression of endogenous chaperones
that aid in proper protein folding, such as Grp78 and Grp94, as
well as UPR mediators, such as ATF-6 and eIF2, was  elevated in
a time-dependent manner in macrophages treated with AGE-alb
compared to C-alb-treated cells, conﬁrming ER-stress induction
under glycoxidative conditions. Macrophage ER stress can be
induced by several intracellular mechanisms elicited by AGE-alb,
including cholesterol accumulation, inﬂammation and oxidative
stress.
Oxoaldehydes such as GAD are generated in inﬂammatory reac-
tions, speciﬁcally mediated by the myeloperoxidase system. This
can contribute to GAD generation in atherosclerotic lesions and
to the local modiﬁcation of albumin and other macromolecules.
In addition, CML  adducts have been found in atherosclerotic
lesions from diabetic and dyslipidemic humans and animal models
(Anderson et al., 1999).
ER membranes are highly sensitive to free cholesterol accumu-
lation, which leads to cytotoxic effects in cells (Feng et al., 2003). In
this regard, it has previously been shown by our group and others
that AGE-alb treatment reduces the expression of both ABCA-1 and
ABCG-1, impairing Apo A-I and HDL-mediated cholesterol efﬂux
and leading to intracellular cholesterol accumulation (de Souza
Pinto et al., 2012; Machado et al., 2006).
We previously identiﬁed a reduction in ABCA-1 macrophage
content in response to both AGE-alb and serum albumin isolated
from poorly controlled diabetes mellitus patients (Machado-Lima
et al., 2010). This was  related to the oxidative stress elicited by AGE-
albumin via NADPH oxidase and by the mitochondrial respiratory
chain (de Souza Pinto et al., 2012) and also to the accumulation of 7-
ketocholesterol that has been found in glycoxidized macrophages
(Iborra et al., 2011).
Moreover, AGE-alb induces the expression of the receptor for
advanced glycation end-products (RAGE) and scavenger recep-
tors involved in the uptake of modiﬁed LDL by macrophages
(Iwashima et al., 2000). RAGE activation elicits NADPH oxidase
activation and the production of ROS, which ultimately lead to NF-
B activation and the transcription of inﬂammatory genes (Basta
et al., 2005). Inﬂammation contributes considerably to atheroge-
nesis and also triggers ER stress via JNK activation (Hotamisligil,cate that in macrophages, endotoxin-free AGE-alb primes these
cells for an inﬂammatory response elicited by S100B calgranulins
or lipopolysaccharides, which then damages the cholesterol efﬂux.
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Fig. 5. Proteasomal inhibition by MG132 is unable to restore ABCA-1 content in macrophages treated with AGE-alb. (A) Mouse peritoneal macrophages were treated for
different periods of time with C- or AGE-alb (2 mg/mL). Equal amounts of cellular protein were loaded onto polyacrylamide gels, and electrophoresis and immunobloting
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sere performed to measure the expression of ubiquitin. (B) Macrophages were tre
nhibitor MG132 (1 M).  ABCA-1 content was determined by ﬂow cytometry in J774
n  = 4).
Aside from the observed increase in ATF6 expression in
acrophages treated with AGE-alb, we did not ﬁnd any alterations
n CHOP expression. In agreement, cellular apoptosis, assessed by
nnexin V, was not different between cells treated with C- and
GE-alb (data not shown).
The level of ABCA-1 protein was reduced by 33% in macrophages
reated with AGE-alb, and treatment with 4-PBA was able to com-
letely restore ABCA-1 levels and Apo A-I-mediated cholesterol
fﬂux in macrophages. The chemical chaperone 4-PBA is known to
mprove ER folding capacity and to facilitate the trafﬁcking of mis-
olded proteins. These effects help to prevent protein aggregation
tabilizing their conformation (Engin and Hotamisligil, 2010). Inr 8 h with C- or AGE-alb (2 mg/mL) in the absence or presence of the proteasomal
ophages (n = 6) and by (C) immunocytochemistry in mouse peritoneal macrophages
diabetic and obese animal models, Ozcan et al. (2006) have shown
that oral administration of 4-PBA was  able to normalize plasma glu-
cose levels and restore systemic insulin sensitivity, separate from
other anti-diabetic effects that were observed even in the absence
of body weight loss.
The association between ER stress and ABCA-1 reduction, which
has not been described so far, was  further strengthened by the
ﬁnding that tunicamycin – a classical ER stress inductor – also
diminishes ABCA-1 and cholesterol efﬂux.
We have also obtained preliminary data demonstrating that
aminoguanidine (an antioxidant and anti-AGE compound) dimin-
ishes the AGE-alb-induced expression of Grp78. Aminoguanidine is
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ble to reduce the generation of ROS in macrophages treated with
GE-alb and also recovers ABCA-1 protein content (de Souza Pinto
t al., 2012). Thus, in our experimental conditions, ER stress is the
ost likely phenomenon linking the redox imbalance to the reduc-
ion in ABCA-1 levels in macrophages under glycoxidative stress,
specially considering the important role this organelle plays in
rotein synthesis/stability.
Since ERAD is part of the UPR, speciﬁcally mediated by the IRE1
nd ATF6 branches, and targets misfolded proteins for degradation
Kincaid and Cooper, 2007), we investigated whether inhibition of
he proteasome had any effect on ABCA-1 protein levels in AGE-
lb-treated macrophages. We  found that proteasome inhibition by
G132 was not able to prevent the ABCA-1 reduction in AGE-
lb-treated macrophages. In addition, the elevated level of total
biquitin found in macrophages suggests proteasomal inhibition
ccording to recent ﬁndings. Moheimani et al. (2010) demon-
trated an impairment in the activity of proteasomal enzymes in
acrophages incubated with GAD-modiﬁed albumin, suggesting a
eleterious effect of oxoaldehydes in the intracellular accumulation
f misfolded and glycated proteins in diabetes mellitus. Nonethe-
ess, the concentration of albumin utilized per milliliter of cell
edium was highly superior when compared to that utilized by us
4 mg/mL  vs. 2 mg/mL, respectively). Also, AGE-alb increases gen-
ration of ROS due to mitochondrial dysfunction (de Souza Pinto
t al., 2012) and considering that the ubiquitin–proteasome com-
lex is a high energy requiring system, the damage in mitochondrial
unction, induced by AGE, may  contribute to the impairment in
roteasomal activity.
Together with the observation that MG132 does not recover
BCA-1 levels, we assume that AGE-alb already damages the pro-
easomal system, which excludes the role of ERAD in ABCA-1
eduction in AGE-treated cells.
Zelcer et al. (2009) previously reported a proteasome-
ndependent pathway for LDL-receptor (B-E receptor) degradation.
n agreement with their ﬁndings, our experimental conditions
howed that ABCA-1 levels do not appear to be regulated by
RAD/ubiquitin-proteasomal degradation. ABCA-1 is a large and
omplex polypeptide, and a wide range of posttranslational modi-
cations carried out by ER machinery are required to reach a ﬁnal
ature conformation. Alteration of one or more of these mecha-
isms could impair the ABCA-1 structure and functionality (Kang
t al., 2010).
Our study describes, for the ﬁrst time, the effect of AGE-alb on
acrophage ER stress, which is indeed associated with ABCA-1
ontent and function impairment in diabetes mellitus. The exact
echanism by which ER stress affects ABCA-1 content remains elu-
ive and requires further investigation. ER dysfunction appears to
lay an important role in a wide range of diseases, including obe-
ity, hepatic steatosis and DM (Hotamisligil, 2010). In this regard,
hemical chaperones, such as 4-PBA, represent an exciting area of
esearch for clinical application and may  contribute to the preven-
ion of atherosclerosis in DM.
. Conclusion
In conclusion, in diabetes mellitus and other carbonyl stress
onditions, despite modiﬁcations in the lipoprotein chemical com-
osition and concentration, advanced glycated albumin contributes
o atherogenesis by inducing ER dysfunction, which relates to the
eduction in ABCA-1-mediated macrophage reverse cholesterol
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